
Sublocade
Buprenorphine
- SKU
- 12496-0100
- UPC
- 0312496030011
- Mfr
- Indivior Inc.
1 solution in 1 syringe, 1 syringe in 1 pouch, 1 pouch in 1 carton
$2,132.89
Price for one pack
Controlled medicine — prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it and confirmed it with your prescriber. How it works
SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
- Strength
- Buprenorphine 100 mg/1
- Unit of measure
- Per 1 solution
- Dosage form
- Solution
- Route
- Subcutaneous
Pharmacologic class
- Partial Opioid AgonistEstablished class
- Partial Opioid AgonistsMechanism
- Brand name
- Sublocade
- Generic name
- Buprenorphine
- Manufacturer
- Indivior Inc.
- Product NDC (SKU)
- 12496-0100
- UPC
- 0312496030011, 0312496010013
- Active ingredients
- Buprenorphine 100 mg/1
- Unit of measure
- Per 1 solution
- Dosage form
- Solution
- Route
- Subcutaneous
- DEA schedule
- CIII
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application number
- NDA209819
- Marketed since
- February 26, 2018
- Label revised
- July 27, 2026
| Package NDC | Description |
|---|---|
| 12496-0100-1 | 1 POUCH in 1 CARTON (12496-0100-1) / 1 SYRINGE in 1 POUCH (12496-0100-2) / 1 SOLUTION in 1 SYRINGE |
Reading this NDC
12496-0100-1
- 01Labeler code
- Indivior Inc.
- 02Product code
- Sublocade, solution
- 03Package code
- 1 pouch in 1 carton (12496-0100-1) / 1 syringe in 1 pouch (12496-0100-2) / 1 solution in 1 syringe
Injection contains buprenorphine. Buprenorphine is a partial agonist at the mu- opioid receptor and an antagonist at the kappa-opioid receptor.
Warning: Risk of serious harm or death with intravenous administration;
SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emboli, if administered intravenously.
Because of the risk of serious harm or death that could result from intravenous self-administration, SUBLOCADE is only available through a restricted program called the SUBLOCADE REMS Program. Healthcare settings and pharmacies that order and dispense SUBLOCADE must be certified in this program and comply with the REMS requirements.
WARNING. RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY See full prescribing information for complete boxed warning. Serious harm or death could result if administered intravenously.
SUBLOCADE is only available through a restricted program called the SUBLOCADE REMS Program. Healthcare settings and pharmacies that order and dispense SUBLOCADE must be certified in this program and comply with the REMS requirements.
SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support. SUBLOCADE contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
SUBLOCADE should be used as part of a complete treatment program that includes counseling and psychosocial support.
Read before you order

Opioid use disorder · 2 min read
How buprenorphine treatment for opioid use disorder works
Buprenorphine and buprenorphine-naloxone explained: how they reduce cravings and withdrawal, how treatment starts and why it is safer than full opioids.

Opioid use disorder · 2 min read
Naloxone: how to recognise and reverse an opioid overdose
How naloxone nasal spray works, the signs of an opioid overdose and step-by-step what to do while you wait for emergency help.

Opioid use disorder · 2 min read
Naltrexone and lofexidine: other medicines for opioid recovery
How naltrexone blocks opioids to prevent relapse, how lofexidine eases withdrawal symptoms, and who each is for.
More in Opioid Use Disorder
View all
Brand · Injection
Brixadi
Buprenorphine 8 mg/.16mL
- SKU
- 58284-208
- Mfr
- Braeburn Inc.
From $441.60Prescription required

Generic · Film
Buprenorphine And Naloxone
Buprenorphine Hydrochloride 8 mg/1, Naloxone Hydrochloride Dihydrate 2 mg/1
- SKU
- 0378-8767
- Mfr
- Mylan Pharmaceuticals Inc.
From $78.99Min. 4 packsPrescription required

Generic · Tablet
Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate
Buprenorphine Hydrochloride 8 mg/1, Naloxone Hydrochloride Dihydrate 2 mg/1
- SKU
- 0406-8020
- Mfr
- SpecGx LLC
From $29.99Min. 11 packsPrescription required

Generic · Tablet
Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate
Buprenorphine Hydrochloride 2 mg/1, Naloxone Hydrochloride Dihydrate .5 mg/1
- SKU
- 51407-948
- Mfr
- Golden State Medical Supply, Inc.
From $21.99Min. 14 packsPrescription required